Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 66Polycystic Ovary Syndrome 3Neoplasms, Hormone-Dependent 3Neoplasm Metastasis 2Carcinoma, Lobular 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Cancer Female 2Advanced Breast Cancer 2Sexuality 1Sexual Dysfunctions, Psychological 1Osteoporosis 1Luminal B/HER2-negative Breast Cancer 1Leiomyoma 1Infertility 1Hot Flashes 1Hormone Receptor Positive Breast Carcinoma 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1Fractures, Bone 1Estrogen Receptor and/or Progesterone Receptor Positive 1Endometrial Stromal Tumors 1Endometrial Neoplasms 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1Arthralgia 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Zoledronic Acid 4Denosumab 4Toremifene 2Vitamin D 1Propofol 1Neuroleptanalgesia 1Midazolam 1Hormone Replacement Therapy 1Etomidate 1Cholecalciferol 1Aspirin 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fractures, Bone × Aromatase Inhibitors × Clear all
NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡